Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Majdi Saleem Naamneh"'
Autor:
Shimon Lecht, Adi Lahiani, Michal Klazas, Majdi Saleem Naamneh, Limor Rubin, Jiayi Dong, Wenhua Zheng, Philip Lazarovici
Publikováno v:
Biomedicines, Vol 12, Iss 7, p 1592 (2024)
Rasagiline (Azilect®) is a selective monoamine oxidase B (MAO-B) inhibitor that provides symptomatic benefits in Parkinson’s disease (PD) treatment and has been found to exert preclinical neuroprotective effects. Here, we investigated the neuropro
Externí odkaz:
https://doaj.org/article/c398299d621e4cf19d068d4532ba31e4
Autor:
Majdi Saleem Naamneh, Tatjana Momic, Michal Klazas, Julius Grosche, Johannes A. Eble, Cezary Marcinkiewicz, Netaly Khazanov, Hanoch Senderowitz, Amnon Hoffman, Chaim Gilon, Jehoshua Katzhendler, Philip Lazarovici
Publikováno v:
Pharmaceuticals, Vol 17, Iss 5, p 549 (2024)
To develop peptide drugs targeting integrin receptors, synthetic peptide ligands endowed with well-defined selective binding motifs are necessary. The snake venom KTS-containing disintegrins, which selectively block collagen α1β1 integrin, were use
Externí odkaz:
https://doaj.org/article/a2507c50643f46cfb8943819957681cd
Publikováno v:
Biomedicines, Vol 10, Iss 12, p 3190 (2022)
The clinical pathology of Taxol-induced peripheral neuropathy (TIPN), characterized by loss of sensory sensitivity and pain, is mirrored in a preclinical pharmacological mice model in which Gabapentin, produced anti-thermal hyperalgesia and anti-allo
Externí odkaz:
https://doaj.org/article/9b993140d77f444eb302a6b1ef96d17d
Publikováno v:
ACS Applied Polymer Materials. 4:7699-7709
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdd307d39d5eee37443599f99eefb7ba
https://doi.org/10.1021/acsapm.2c01256
https://doi.org/10.1021/acsapm.2c01256